"Sentinel Lymph Node" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
First lymph node to receive drainage from the primary tumor. SENTINEL LYMPH NODE BIOPSY is performed to determine early METASTASIS status because cancer cells may appear first in the sentinel node.
| Descriptor ID |
D000071036
|
| MeSH Number(s) |
A10.549.400.750 A15.382.520.604.412.750
|
| Concept/Terms |
Sentinel Lymph Node- Sentinel Lymph Node
- Lymph Node, Sentinel
- Lymph Nodes, Sentinel
- Sentinel Lymph Nodes
- Sentinal Node
- Node, Sentinal
- Nodes, Sentinal
- Sentinal Nodes
|
Below are MeSH descriptors whose meaning is more general than "Sentinel Lymph Node".
Below are MeSH descriptors whose meaning is more specific than "Sentinel Lymph Node".
This graph shows the total number of publications written about "Sentinel Lymph Node" by people in this website by year, and whether "Sentinel Lymph Node" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 2016 | 5 | 3 | 8 |
| 2017 | 10 | 0 | 10 |
| 2018 | 4 | 1 | 5 |
| 2019 | 5 | 2 | 7 |
| 2020 | 1 | 0 | 1 |
| 2021 | 5 | 1 | 6 |
| 2022 | 10 | 0 | 10 |
| 2023 | 11 | 0 | 11 |
| 2024 | 5 | 2 | 7 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Sentinel Lymph Node" by people in Profiles.
-
Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial. Ann Surg Oncol. 2025 May; 32(5):3278-3291.
-
Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy. Ann Surg Oncol. 2025 Feb; 32(2):922-930.
-
Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer. Ann Surg Oncol. 2025 Jan; 32(1):84-91.
-
The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer. Ann Surg Oncol. 2024 Oct; 31(11):7339-7346.
-
Risks and benefits of sentinel lymph node evaluation in the management of endometrial intraepithelial neoplasia. Expert Rev Anticancer Ther. 2024 Aug; 24(8):745-753.
-
Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial. Ann Surg Oncol. 2024 Oct; 31(11):7249-7259.
-
Correspondence on "Sentinel lymph node assessment in patients with atypical endometrial hyperplasia: a systematic review and meta-analysis" by Vieira-Serna et al. Int J Gynecol Cancer. 2024 04 01; 34(4):654.
-
Sentinel lymph node biopsy is unreliable in predicting melanoma mortality for both younger and older patients. J Eur Acad Dermatol Venereol. 2024 Apr; 38(4):741-751.
-
Reply to: "Is Choosing Wisely Wise for Lobular Carcinoma in Patients Over 70 Years of Age? A National Cancer Database Analysis of Sentinel Node Practice Patterns. Ann Surg Oncol. 2024 03; 31(3):1669-1670.
-
To Dissect or Not to Dissect: Can We Predict the Presence of Four or More Axillary Lymph Node Metastases in Postmenopausal Women with Clinically Node-Negative Breast Cancer? Ann Surg Oncol. 2023 Dec; 30(13):8327-8334.